|
Cemiplimab-Rwlc Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Libtayo
Washington D.C., District of Columbia1 trial
Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Involvement
Lombardi Comprehensive Cancer Center, Georgetown University
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.